Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials.
about
Intermittent preventive treatment of malaria in pregnant women and infants: making best use of the available evidenceIntermittent preventive treatment for malaria in children living in areas with seasonal transmissionIntermittent preventive treatment for malaria in infantsCombination of probenecid-sulphadoxine-pyrimethamine for intermittent preventive treatment in pregnancySelection of drug resistance-mediating Plasmodium falciparum genetic polymorphisms by seasonal malaria chemoprevention in Burkina FasoDeclining trend of Plasmodium falciparum dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant alleles after the withdrawal of Sulfadoxine-Pyrimethamine in North Western EthiopiaDuration of protection against clinical malaria provided by three regimens of intermittent preventive treatment in Tanzanian infantsIntermittent preventive treatment in infants for the prevention of malaria in rural Western kenya: a randomized, double-blind placebo-controlled trialThe cost-effectiveness of intermittent preventive treatment for malaria in infants in Sub-Saharan AfricaTwo strategies for the delivery of IPTc in an area of seasonal malaria transmission in the Gambia: a randomised controlled trialIntermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Mali: a randomised, double-blind, placebo-controlled trialA systematic review and meta-analysis of the efficacy and safety of intermittent preventive treatment of malaria in children (IPTc)Determinants of the cost-effectiveness of intermittent preventive treatment for malaria in infants and childrenIntermittent preventive treatment for malaria in Papua New Guinean infants exposed to Plasmodium falciparum and P. vivax: a randomized controlled trialProtective efficacy and safety of three antimalarial regimens for the prevention of malaria in young Ugandan children: a randomized controlled trialSafety, immunogenicity and duration of protection of the RTS,S/AS02(D) malaria vaccine: one year follow-up of a randomized controlled phase I/IIb trialBiochemical and functional characterization of Plasmodium falciparum GTP cyclohydrolase IMalaria in childrenIntermittent preventive treatment: efficacy and safety of sulfadoxine-pyrimethamine and sulfadoxine-pyrimethamine plus piperaquine regimens in schoolchildren of the Democratic Republic of Congo: a study protocol for a randomized controlled trial.Tracing the origins and signatures of selection of antifolate resistance in island populations of Plasmodium falciparumPrevention of the recurrence of anaemia in Gambian children following discharge from hospital.Molecular markers of resistance to sulphadoxine-pyrimethamine one year after implementation of intermittent preventive treatment of malaria in infants in Mali.Protective efficacy of intermittent preventive treatment of malaria in infants (IPTi) using sulfadoxine-pyrimethamine and parasite resistance.Efficacy, safety, and tolerability of three regimens for prevention of malaria: a randomized, placebo-controlled trial in Ugandan schoolchildren.Influences of intermittent preventive treatment and persistent multiclonal Plasmodium falciparum infections on clinical malaria risk.Intermittent preventive treatment to reduce the burden of malaria in children: new evidence on integration and deliveryIndependent lineages of highly sulfadoxine-resistant Plasmodium falciparum haplotypes, eastern Africa.Intermittent preventive treatment for malaria in sub-saharan African: a halfway technology or a critical intervention?Origins of the recent emergence of Plasmodium falciparum pyrimethamine resistance alleles in Madagascar.Modelling the protective efficacy of alternative delivery schedules for intermittent preventive treatment of malaria in infants and children.Increase in EPI vaccines coverage after implementation of intermittent preventive treatment of malaria in infant with Sulfadoxine -pyrimethamine in the district of Kolokani, Mali: results from a cluster randomized control trial.Malaria morbidity in children in the year after they had received intermittent preventive treatment of malaria in Mali: a randomized control trialMorbidity from malaria in children in the year after they had received intermittent preventive treatment of malaria: a randomised trial.Immunological consequences of intermittent preventive treatment against malaria in Senegalese preschool children.Multiplicity of Plasmodium falciparum infection following intermittent preventive treatment in infants.Anti-folate drug resistance in Africa: meta-analysis of reported dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant genotype frequencies in African Plasmodium falciparum parasite populations.Intermittent preventive treatment with sulfadoxine-pyrimethamine does not modify plasma cytokines and chemokines or intracellular cytokine responses to Plasmodium falciparum in Mozambican children.Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and eliminationIntermittent preventive treatment for malaria in infants: a decision-support tool for sub-Saharan AfricaAnti-malarial drugs and the prevention of malaria in the population of malaria endemic areas.
P2860
Q21032450-1F853A3E-3D34-4FBF-8DB2-9C59BD81582BQ21032527-67D4AEEF-98F4-4C47-90D4-F168F4306EF4Q24188349-55E02C67-B9BE-4310-A164-131DE0A44504Q27005614-105E1F6F-AC22-416F-BB09-6C21D670A845Q28125901-2FC76B9E-7ADB-420F-8B1F-E742FA341F2BQ28125927-330EDD11-FCAC-48C6-8CC1-D8B62EEED422Q28473083-B3A71585-3D84-4CC8-9FFD-9A62C50EA6C2Q28473566-A39BC2C3-D9BF-4485-9A02-E79CF26D5070Q28474404-BC1A16E7-E2A2-4E60-87A4-8295D371B1E0Q28477047-69B4C340-84E0-4FC7-B9FD-4D321AB368B4Q28477050-9D2A456B-D4B9-42A3-96A3-3B569B060DC9Q28477153-9F480BC9-F098-44A3-B730-65246F8B04DEQ28477679-527109BF-7217-48DD-9A44-252E97D84636Q28481649-08D34087-A9F3-474F-87BE-9433FE1F83AAQ28541598-5244B46A-CDBF-4CB9-B393-B28E584B8A0DQ28748565-2C07A7F4-FCF7-48DC-8FD9-C8CA2DC5773DQ30044485-28D5DFC4-C4AF-4957-82DF-2568ECA4EEEFQ33404647-AE52DF42-5669-46A5-A11D-0F827D3E6211Q33589334-8DE0F768-CBA4-41E3-873B-41D9C8D277BCQ33599358-E2DB352E-54F8-45E1-B8ED-7006DCC0603FQ33614729-EA595EFF-A82D-4DA0-A355-4118F423F830Q33645358-AD3E6CC5-AF0D-49B5-A58A-895AEAE83B57Q33691573-A9CF4FE5-6D48-41AC-9CB0-AD7EE71113FAQ33728165-C1672EC0-F513-4C81-94DB-33F948397170Q33737542-7A665343-E6FE-439F-9DAD-994CC9495154Q33815505-54311462-DED8-4F6D-9D84-A23542411277Q33816411-A2F53B77-3787-4522-B9EA-E54AA3FA79B8Q33817498-375475F9-BDFE-446E-9C45-898246B47965Q33876441-64258365-4AD1-4BD4-9959-944FCE7EDF21Q33886209-C1459ADF-4774-4349-9F15-8629BD771462Q33964491-D9B37B0F-AE0F-432F-9A54-50FE38BB256CQ33999551-001B415D-026E-4985-A536-814B39F48F8AQ33999559-DC9272C2-CFF8-4932-8761-48404737FF2CQ34025033-6E43FA1C-8704-4B30-9817-4FCC81F36037Q34128601-B2D5D80A-5800-46AF-A424-91C2CF750A70Q34134036-A2C89215-F8E7-4E0C-84E8-8713303DBE33Q34142179-B1B4CF63-A4FA-431B-B0D4-20347813F436Q34177472-1CFE1C06-9A86-4927-BD95-CC493926F4ABQ34271078-6DCFC1CA-A716-408D-BB0B-C5CF86E0B9A2Q34407217-C843A141-DF1E-4B46-8C5E-B87E020CC829
P2860
Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Efficacy and safety of intermi ...... ed, placebo-controlled trials.
@en
Efficacy and safety of intermi ...... ed, placebo-controlled trials.
@nl
type
label
Efficacy and safety of intermi ...... ed, placebo-controlled trials.
@en
Efficacy and safety of intermi ...... ed, placebo-controlled trials.
@nl
prefLabel
Efficacy and safety of intermi ...... ed, placebo-controlled trials.
@en
Efficacy and safety of intermi ...... ed, placebo-controlled trials.
@nl
P2093
P50
P921
P1433
P1476
Efficacy and safety of intermi ...... ed, placebo-controlled trials.
@en
P2093
Alasdair Breckenridge
Alexander Dodoo
Andrea Egan
Clara Menendez
David Schellenberg
Esperanza Sevene
Eusebio Macete
Ilona Carneiro
Jürgen May
Peter Winstanley
P304
P356
10.1016/S0140-6736(09)61258-7
P407
P50
P577
2009-09-16T00:00:00Z